| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 234.68M | 214.44M | 195.28M | 220.85M | 223.37M |
| Gross Profit | 102.42M | 103.50M | 99.54M | 131.79M | 141.13M |
| EBITDA | 103.55M | 105.99M | 94.93M | 131.50M | 141.22M |
| Net Income | -76.63M | 50.86M | 37.31M | 33.81M | 84.18M |
Balance Sheet | |||||
| Total Assets | 384.95M | 440.29M | 462.19M | 443.05M | 520.59M |
| Cash, Cash Equivalents and Short-Term Investments | 80.10M | 67.32M | 56.83M | 60.30M | 55.70M |
| Total Debt | 2.17M | 1.72M | 1.83M | 1.70M | 33.61M |
| Total Liabilities | 100.04M | 88.58M | 82.13M | 74.92M | 111.34M |
| Stockholders Equity | 284.67M | 353.20M | 381.31M | 369.44M | 410.56M |
Cash Flow | |||||
| Free Cash Flow | 47.45M | 53.02M | 38.55M | 82.45M | 97.91M |
| Operating Cash Flow | 66.87M | 74.26M | 66.41M | 99.84M | 112.61M |
| Investing Cash Flow | -16.93M | -22.71M | -25.97M | -13.69M | -14.53M |
| Financing Cash Flow | -37.26M | -40.96M | -44.00M | -81.49M | -86.59M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | £37.24B | 32.06 | 10.67% | 0.92% | 13.52% | 38.75% | |
65 Neutral | £1.21B | 16.42 | 15.06% | 0.74% | 23.97% | 216.41% | |
63 Neutral | £280.15M | -5.82 | -22.86% | 5.15% | 5.70% | -9.60% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
47 Neutral | £278.99M | 13.71 | -12.56% | ― | 129.53% | 70.68% | |
45 Neutral | £19.70M | ― | ― | ― | ― | ― |